249 research outputs found
Reporäntans påverkan på svenska branschindex
Examensarbetets titel: Reporäntans påverkan på svenska branschindex Seminariedatum: 2015-01-15 Ämne/kurs: FEKH89 Examensarbete i finansiering på kandidatnivå, 15 HP Författare: Richard Eek, Martin Klarin, Christofer Karlsson Handledare: Erling Green Fem nyckelord: Reporänta, onormal avkastning, händelsestudie, branschindex, ränteförändring. Syfte: Syftet med den här uppsatsen är att utreda marknadseffektiviteten samt vilken inverkan en justering av reporäntan har på olika branschindex på den svenska aktiemarknaden. Metod: Vi har genomfört en kvantitativ studie och genom en händelsestudie undersökt den onormala avkastningen för 8 olika branschindex på Nasdaq Stockholm. Teoretiska perspektiv: Uppsatsen utgår från tidigare forskning om hur en ränteförändring påverkar aktiemarknaden. Vi har utgått från studier som har gjorts på den svenska och amerikanska aktiemarknaden. Empiri: Vi har valt ut 8 olika branschindex på Nasdaq Stockholm. De indexen vi har valt ger ett bra urval av olika delar av aktiemarknaden. Indexen är Oil & gas, Basic materials, Industrials, Consumer goods, Consumer service, Health care, Technology och Financials. Resultat: Våra resultat visar att marknaden är inte är effektiv. Marknaden prisar inte in en ränteförändring direkt, utan det finns tecken både på att det sker en fördröjd reaktion från marknaden och att marknaden prisar in ränteförändringen redan innan den har skett. Vi har även sett att det förekommer skillnader i den kumulativa avkastningen mellan olika branschindex
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
Bruton tyrosine kinase (BTK) inhibitors have greatly
improved the spectrum of treatment options in mantle cell
lymphoma (MCL) [1–4]. Acalabrutinib is a highly selective,
orally administered, and potent BTK inhibitor with limited
off-target activity [5]. Acalabrutinib was approved in 2017
by the US Food and Drug Administration for the treatment
of relapsed/refractory MCL based on clinical data from the
open-label, multicenter, phase 2 ACE-LY-004 study of
acalabrutinib 100 mg twice daily [1]. Here, we present
updated results from the ACE-LY-004 study after a median
26-month follow-up.
Eligibility criteria and study design were published previously (Supplementary methods) [1]. Analysis of minimal
residual disease (MRD) was conducted after complete
response (CR) or partial response (PR) was achieved
using the quantitative ClonoSEQ next-generation sequencing (5 × 10−6
) assay (Adpative Biotechnologies, Seattle,
WA, USA) in consenting patients with available paired
archival tumor and whole blood samples. Data are updated
as of February 12, 2018
Test beam results of a stereo preshower integrated in the liquid argon accordion calorimeter
This paper describes the construction of an integrated preshower within the RD3 liquid argon accordion calorimeter. It has a stereo view which enables the measurement of two transverse coordinates. The prototype was tested at CERN with electrons, photons and muons to validate its capability to work at LHC ( Energy resolution, impact point resolution, angular resolution, / rejection )
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
Limits on the production of scalar leptoquarks from Z (0) decays at LEP
A search has been made for pairs and for single production of scalar leptoquarks of the first and second generations using a data sample of 392000 Z0 decays from the DELPHI detector at LEP 1. No signal was found and limits on the leptoquark mass, production cross section and branching ratio were set. A mass limit at 95% confidence level of 45.5 GeV/c2 was obtained for leptoquark pair production. The search for the production of a single leptoquark probed the mass region above this limit and its results exclude first and second generation leptoquarks D0 with masses below 65 GeV/c2 and 73 GeV/c2 respectively, at 95% confidence level, assuming that the D0lq Yukawa coupling alpha(lambda) is equal to the electromagnetic one. An upper limit is also given on the coupling alpha(lambda) as a function of the leptoquark mass m(D0)
Invariant mass dependence of particle correlations in hadronic final states from the decay of the Z
In situ sediment treatment using activated carbon: a demonstrated sediment cleanup technology
This paper reviews general approaches for applying activated carbon (AC) amendments as an in situ sediment treatment remedy. In situ sediment treatment involves targeted placement of amendments using installation options that fall into two general approaches: 1) directly applying a thin layer of amendments (which potentially incorporates weighting or binding materials) to surface sediment, with or without initial mixing; and 2) incorporating amendments into a premixed, blended cover material of clean sand or sediment, which is also applied to the sediment surface. Over the past decade, pilot- or full-scale field sediment treatment projects using AC—globally recognized as one of the most effective sorbents for organic contaminants—were completed or were underway at more than 25 field sites in the United States, Norway, and the Netherlands. Collectively, these field projects (along with numerous laboratory experiments) have demonstrated the efficacy of AC for in situ treatment in a range of contaminated sediment conditions. Results from experimental studies and field applications indicate that in situ sequestration and immobilization treatment of hydrophobic organic compounds using either installation approach can reduce porewater concentrations and biouptake significantly, often becoming more effective over time due to progressive mass transfer. Certain conditions, such as use in unstable sediment environments, should be taken into account to maximize AC effectiveness over long time periods. In situ treatment is generally less disruptive and less expensive than traditional sediment cleanup technologies such as dredging or isolation capping. Proper site-specific balancing of the potential benefits, risks, ecological effects, and costs of in situ treatment technologies (in this case, AC) relative to other sediment cleanup technologies is important to successful full-scale field application. Extensive experimental studies and field trials have shown that when applied correctly, in situ treatment via contaminant sequestration and immobilization using a sorbent material such as AC has progressed from an innovative sediment remediation approach to a proven, reliable technology
Autonomous navigation for inspection and maintenance ground robotics
This chapter presents recent research results in the frame of Autonomous Navigation for Inspection and Maintenance Ground Robotics including localization and navigation algorithms, as well as Localization and Mapping of Ground Robots
- …